prikaz prve stranice dokumenta Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report
  Preuzmi
PDF 1.68 MB
Znanstveni rad - Izvorni znanstveni rad
Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report
Frontiers in Oncology, 13 (2023); 1260989. https://doi.org/10.3389/fonc.2023.1260989
Adžić, Gordan; Prejac, Juraj; Pleština, Stjepko

Institucijski repozitorij: Repozitorij stomatološkog fakulteta u Zagrebu

Citirajte ovaj rad

Adžić, G., Prejac, J. i Pleština, S. (2023). Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report. Frontiers in Oncology, 13.. doi: 10.3389/fonc.2023.1260989

Adžić, Gordan, et al. "Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report." Frontiers in Oncology, vol. 13, 2023. https://doi.org/10.3389/fonc.2023.1260989

Adžić, Gordan, Juraj Prejac i Stjepko Pleština. "Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report." Frontiers in Oncology 13 (2023). https://doi.org/10.3389/fonc.2023.1260989

Adžić, G., Prejac, J. i Pleština, S. (2023) 'Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report', Frontiers in Oncology, 13. doi: 10.3389/fonc.2023.1260989

Adžić G, Prejac J, Pleština S. Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report. Frontiers in Oncology [Internet]. 10.10.2023. [pristupljeno 09.07.2024.];13. doi: 10.3389/fonc.2023.1260989

G. Adžić, J. Prejac i S. Pleština, "Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report", Frontiers in Oncology, vol. 13, Listopad 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:127:515500. [Citirano: 09.07.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:127:515500
Podaci o radu
Naslov (engleski)Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report
AutorGordan Adžić
AutorJuraj Prejac
AutorStjepko Pleština
Autorova ustanova(Klinički bolnički centar Zagreb)
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Autorova ustanovaSveučilište u Zagrebu
Stomatološki fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Introduction: Hepatocellular carcinoma (HCC) accounts for approximately 90% of primary liver cancer and can be caused by well-known risk factors, including infection with hepatitis B and C viruses, alcohol intake, and metabolic syndrome. The overall prognosis remains poor with a median survival of 1 year for symptomatic advanced-stage cases treated with systemic therapies. Case description In July 2020, a 73-year-old male patient presented at our institution with mild abdominal pain and an attack of intense cold. After a radiological workup, the diagnosis of HCC located in the caudate lobe was established. The patient underwent atypical caudate lobe resection, and pathology confirmed the diagnosis of grade 3 HCC. Postoperative MRI showed a new metastasis in the 6th liver segment 1.3 cm in diameter, and a PVT progression which now affected the whole right lobe. The patient was started on sorafenib and demonstrated a complete response which still lasts for more than two years. Conclusion: We present a rare case of a patient who demonstrated a complete response to sorafenib treatment in advanced HCC with unfavorable prognostic factors.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaFrontiers in Oncology
Brojčani podacivol. 13, 1260989
e-ISSN2234-943X
DOIhttps://doi.org/10.3389/fonc.2023.1260989
URN:NBNurn:nbn:hr:127:515500
Datum objave publikacije2023-10-10
URL dokumentahttps://www.frontiersin.org/articles/10.3389/fonc.2023.1260989/full
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2024-07-02 11:20:01